About LeMaitre Vascular
LeMaitre Vascular is a publicly listed company based in Burlington (United States) founded in 1983. Devices for peripheral vascular disease treatment are developed and marketed. LeMaitre Vascular has raised $4.38 million across 7 funding rounds. The company has 664 employees. LeMaitre Vascular has completed 5 acquisitions, including Artegraft, Duke Vascular and Inavein. Its website lemaitre.com draws about 15 thousand monthly visits. LeMaitre Vascular offers products and services including AlboGraft®, RestoreFlow®, Pruitt®, and AnastoClip®. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is LeMaitre Vascular, Inc. Its competitors include Avinger, Pathway Medical Technologies and Intact Vascular; 3 of its 3 listed competitors have raised funding.
Company details
LeMaitre Vascular was founded in 1983 and focuses on the development, manufacturing, and marketing of medical devices and implants for peripheral vascular disease. Products such as embolectomy catheters, occlusion catheters, perfusion catheters, and carotid shunts are produced. Operations extend worldwide from the headquarters in Burlington, United States. The company, formerly known as Vascutech, underwent a name change in April 2001.
- Headquarters Burlington, United States
- Employees 664
- Stage Public
- SectorsHealthcare
- Website lemaitre.com
- Social LinkedIn YouTube
- Legal Name Lemaitre Vascular, Inc.
- Annual Revenue$249.6 M (USD)13.53as on Dec 31, 2025
- Net Profit$57.73 M (USD)31.1as on Dec 31, 2025
- EBITDA$78.33 M (USD)26.34as on Dec 31, 2025
- Total Equity Funding$4.38M (USD)
in 7 rounds
- Latest Funding Round$25K (USD), Series A
Sep 2005
- Employee Count664
- Investments & AcquisitionsArtegraft
& 4 more
Products & Services of LeMaitre Vascular
LeMaitre Vascular offers a comprehensive portfolio of products and services, including AlboGraft®, RestoreFlow®, Pruitt®, and AnastoClip®.
Polyester grafts for aortic repair and vascular procedures
Allografts for cardiac and vascular reconstruction
Catheters used for vascular occlusion in surgeries
Devices for secure vascular closure during procedures
Apps and channels of LeMaitre Vascular
its YouTube channel LeMaitre has 389 subscribers and 30 videos.
Videos from LeMaitre Vascular
The most watched videos on LeMaitre Vascular's YouTube channel, LeMaitre (389 subscribers). Click a video to play it here.
More on LeMaitre.
Funding Insights of LeMaitre Vascular
LeMaitre Vascular has successfully raised a total of $4.38M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $25 thousand completed in September 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.38M
- Total Rounds 7
- Last Round Series A — $25,000
- First Round $800,000
(Jun 2002)
All 7 funding rounds of LeMaitre Vascular with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2005 | $25,000 | Series A | – | – | – |
| Aug 2005 | $2.25M | Series A | – | – | – |
| Feb 2005 | $2.1M | Series A | – | – | – |
| Jun 2004 | $200,000 | Unspecified | – | – | – |
| Apr 2003 | $380,720 | Unspecified | – | – | – |
| Dec 2002 | $75,000 | Unspecified | – | – | – |
| Jun 2002 | $800,000 | Unspecified | – | – | – |
People of LeMaitre Vascular
103 people are tracked at LeMaitre Vascular (35 in leadership, 68 in team); the tracked headcount is 664.
| Name | Role | Group |
|---|---|---|
Bhavana Mungara | Director, IT Business Applications | Leadership |
David B. Roberts | President & Board Director | Leadership |
Ryan H. Connelly | VP, Research & Development | Leadership |
Roli Kumar-Choudhury | Vice President Of Quality Affairs | Leadership |
Stéphane Maier | VP, EMEA Operations | Leadership |
Chance Kriesel | VP, Sales, The Americas | Leadership |
Jonathan W. Ngau | VP, Information Technology | Leadership |
James Russell | Director, Operations | Leadership |
Joseph P. Pellegrino Jr. | CFO & Board Director | Leadership |
George W. LeMaitre | Chairman & CEO | Leadership |
Xiang Zhang | VP, Regulatory Affairs | Leadership |
Helen Goulding | Director, Northern Europe | Leadership |
Daniel J. Mumford | Director, Human Resources | Leadership |
Kathryn L. Tebbe | Senior Director, Financial Reporting | Leadership |
Jj Pellegrino | Chief Financial Officer And Board Member | Leadership |
Ken Watson | Regional Sales Director | Leadership |
Nathaniel Ulrich | General Counsel And Chief Compliance Officer (interim) | Leadership |
Luke McInnis | Vice President, Business Development | Leadership |
Yuxi Meng | Director, Business Development (m&a) | Leadership |
Karen K. | Director Of Operations-allografts Lemaitre Vascular | Leadership |
83 more people are available in the full profile.
Complete people profiles for LeMaitre Vascular
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of LeMaitre Vascular
LeMaitre Vascular is a publicly listed company on the NASDAQ with ticker symbol LMAT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date19 Oct 2006
- Listed onNASDAQ: LMAT
- Listed entityLeMaitre Vascular, Inc.
- Exchange sectorHealth technology
- ISINUS5255582018
- Share price$81.55 (-1.64% on the day) · 2026-10-13
- Market capitalisation$1.86B
- Price to earnings29.1
- EPS (diluted, trailing year)$2.81
- Dividend yield1.16%
- Volume (last session)247,757
Financials of LeMaitre Vascular
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $249.6M | $57.7M | $78.3M |
| 2024 | $219.9M | $44.0M | $62.0M |
| 2023 | $193.5M | $30.1M | $46.6M |
| 2022 | $161.7M | $20.6M | $39.2M |
| 2021 | $154.4M | $26.9M | $45.9M |
Detailed financial statements for LeMaitre Vascular
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LeMaitre Vascular
LeMaitre Vascular has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Artegraft, Duke Vascular and Inavein.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Bovine carotid artery grafts are provided as medical devices. | artegraft.com | North Brunswick, United States | 1993 | Jun 2020 | $90M | |
Regenerative medicines from human tissues are developed for multiple diseases. | restoreflow.com | Fox River Grove, United States | 2013 | Nov 2016 | $14M | |
Varicose and spider vein treatment devices are developed and marketed. | inavein.com | Lexington, United States | 2007 | Aug 2013 | $2.5M | |
Rupture management kits and tracker delivery systems are manufactured. | dukevascular.com | Santa Cruz, United States | 2008 | Jun 2011 | •••• | |
Devices for peripheral vascular disease and nonvascular obstructions are developed. | vasculararchitects.com | San Jose, United States | 1999 | Sep 2007 | $2.8M |
Complete acquisition details for LeMaitre Vascular
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of LeMaitre Vascular
9 dated milestones of LeMaitre Vascular across 37 years, from founding to its latest funding, stage changes and deals.
- Founded LeMaitre Vascular is founded.
- Funding First funding round of $800K.
- Funding Latest funding round, Series A, of $25K.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Vascular Architects.
- Acquisition Acquires Duke Vascular.
- Acquisition Acquires Inavein.
- Acquisition Acquires RestoreFlow Allografts.
- Acquisition Acquires Artegraft.
Competitors of LeMaitre Vascular
LeMaitre Vascular has 3 listed competitors in our database, 3 of them funded. They include Avinger, Pathway Medical Technologies and Intact Vascular.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| avinger.com | 2007 | Redwood, United States | $170.85M | 80 | Provider of image-guided catheter-based products for peripheral artery disease | |
| pathwaymedical.com | 1998 | Kirkland, United States | $101.93M | 158 | Smart devices are provided to clear peripheral arterial blockages. | |
| intactvascular.com | 2011 | Wayne, United States | $123.4M | 64 | Implants for repairing arteries after angioplasty are developed. |
Detailed competitors of LeMaitre Vascular
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of LeMaitre Vascular
The website of LeMaitre Vascular (lemaitre.com) receives about 14.9K visits a month.
- Monthly visits14.9K
▼ 9.6% vs previous month
Websites whose visitors overlap most with LeMaitre Vascular. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
shaileehealthcare.com | shaileehealthcare.com | 100% | – | ||
panmed.co.uk | panmed.co.uk | 100% | – | ||
meigaoyi.com | meigaoyi.com | 100% | – | ||
careflex.co.uk | careflex.co.uk | 100% | #4,332,086 | – | |
leisegang.com | leisegang.com | 100% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 23 similar websites and full traffic analytics for LeMaitre Vascular
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 23 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as LeMaitre Vascular (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lemaitre Vascular
Complete news archive for LeMaitre Vascular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LeMaitre Vascular
LeMaitre Vascular was founded in 1983 and raised its 1st funding round 19 years after it was founded.
LeMaitre Vascular is headquartered in Burlington, United States. It is registered at Burlington, Vermont, United States.
LeMaitre Vascular is a funded company, having raised a total of $4.38M across 7 funding rounds to date. The company's 1st funding round was a Unspecified of $800K, raised on Jun 2002.
LeMaitre Vascular has 664 employees.
Annual revenue of LeMaitre Vascular is $249.6M as on Dec 31, 2025.
LeMaitre Vascular was founded in 1983 and focuses on the development, manufacturing, and marketing of medical devices and implants for peripheral vascular disease. Products such as embolectomy catheters, occlusion catheters, perfusion catheters, and carotid shunts are produced. Operations extend worldwide from the headquarters in Burlington, United States. The company, formerly known as Vascutech, underwent a name change in April 2001.
LeMaitre Vascular's top competitors include Avinger, Intact Vascular and Pathway Medical Technologies.
LeMaitre Vascular offers AlboGraft®, RestoreFlow®, Pruitt®, and AnastoClip®.
Yes, LeMaitre Vascular is publicly traded on NASDAQ under the ticker symbol LMAT.
LeMaitre Vascular has made 5 acquisitions, including Artegraft, Duke Vascular, and Inavein.
LeMaitre Vascular operates through Lemaitre Vascular, Inc..